Enter your login e-mail to the account
Search
- The neuromyelitis optica spectrum disorders
doc. MUDr. Jarmila Szilasiová, PhD.
(5/2019, Review articles ) - The use of monoclonal antibodies in neurology
prof. MUDr. Egon Kurča, PhD., MUDr. Mária Cuninková
(6/2011, Main topic ) - Vaccination in patients receiving complement inhibitor therapy – guidelines for clinical practice
prof. MUDr. Mgr. Miloš Jeseňák, PhD., MBA, Dott.ric., MHA, FAAAAI, MUDr. Anna Ružinák Bobčáková, PhD., MUDr. Pavel Kosina, PhD., prof. MUDr. Roman Chlíbek, PhD., MUDr. Petra Nytrová, PhD., doc. MUDr. Ingrid Urbančíková, PhD., MPH
(1/2026, Informations ) - Orphan drugs in treatment of rare neuromuscular disorders
doc. MUDr. Peter Špalek, PhD.
(2/2021, Main topic ) - New treatment options for Neuromyelitis optica spectrum disorders (NMOSD)
prof. MUDr. Jarmila Szilasiová, PhD.
(3/2024, Review articles ) - Monoklonální protilátky v léčbě roztroušené sklerózy
MUDr. Marek Peterka , MUDr. Zdeněk Kasl, Ph.D.
(2/2018, Pharmacotherapy ) - Ravulizumab in treatment of AQP4-IgGpos Neuromyelitis Optica Spectrum Disorder
MUDr. Petra Nytrová, Ph.D., MUDr. Ingrid Menkyová, Ph.D.
(6/2024, Review articles ) - Guillain–Barré polyradiculoneuritis
MUDr. František Cibulčík, PhD.
(1/2016, Main topic ) - Complement inhibitors eculizumab and ravulizumab in the treatment of generalized myasthenia gravis (gMG)
MUDr. Ivan Martinka, PhD.
(5/2024, Review articles )
- Complement-mediated thrombotic microangiopathy emphasizing renal involvement in children
doc. MUDr. Miroslava Brndiarová, PhD., MUDr. Nikola Haláčová, MUDr. Júlia Kvaššayová, PhD., prof. MUDr. Miloš Jeseňák, PhD.
(2/2025, Case reports )












